The European Medicines Agency (EMA) has approved the Pfizer-BioNTech COVID-19 vaccine for use in children aged 12 to 15, likely pushing back the date by which Europe will have surplus jabs to share with the developing world.
The EMA's human medicines committee said a trial in 2,260 children found the vaccine was safe for use, with no unusual side effects.
"Extending the protection of a safe and effective vaccine in this younger population is an important step forward in the fight against the pandemic," Marco Cavaleri, the EMA's head of biological health threats and vaccines strategy, told reporters.
Read more: https://newseu.cgtn.com/news/2021-05-29/EU-drugs-regulator-backs-Pfizer-jab-for-use-in-12-to-15-year-olds-10DAY1mdJzW/index.html
📲 Follow CGTN Europe on social media and other platforms👇🏼